Long-term outcomes after haploidentical stem cell transplantation (haplo-SCT) for hematologic malignancies | ORKG Ask

We use cookies to provide a better user experience.

Data Protection

Related items

Long-Term Survival and Late Effects among One-Year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Syndromes

January 2015

We analyzed the outcomes of patients who survived disease-free for 1 year or more after a second all...

Treatment Pathways and Health Outcomes of German Patients with Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Health Claims Data Analysis

Scheid, Christof
Kudernatsch, Robert
Eckart, Marie
Feig, Chiara
Straub, Vincent
Libutzki, Berit
Mahlich, Jörg

December 2022

Background: Although chronic graft-versus-host-disease (cGvHD) is an important long-term complicatio...

Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study

Greinix, Hildegard T
Eikema, Dirk-Jan
Koster, Linda
Penack, Olaf
Yakoub-Agha, Ibrahim
Montoto, Silvia
Chabannon, Christian
Styczynski, Jan
Nagler, Arnon
Robin, Marie
Robinson, Stephen
Chalandon, Yves
Mikulska, Malgorzata
Schönland, Stefan
Peric, Zinaida
Ruggeri, Annalisa
Lanza, Francesco
De Wreede, Liesbeth C
Mohty, Mohamad
Basak, Grzegorz W
Kröger, Nicolaus

January 2022

Acute graft-versus-host disease (aGvHD) remains a major threat to successful outcome after allogenei...

Favorable Outcomes in Patients Surviving 5 or More Years after Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies

Le, Robert Quan
Bevans, Margaret
Savani, Bipin N.
Mitchell, Sandra A.
Stringaris, Kate
Koklanaris, Eleftheria
Barrett, A. John

August 2010

Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative treatment for some hematolog...

Outcomes of Older Patients Undergoing 2-Step Approach to Haploidentical and Matched Related Peripheral Blood Hematopoietic Stem Cell Transplantation (HSCT): A Single Institutional Experience

Gaballa, MD, Sameh
Alpdogan, MD, Seyfettin Onder
Carabasi, MD, Matthew
Filicko-O\u27Hara, MD, Joanne
Kasner, MD, Margaret
Leiby, PhD, Benjamin E
Martinez-Outshoorn, MD, Ubaldo E.
Pequignot, MD, Edward C
Rosado, Sarah
Rudolph, MS, Shannon
Wagner, MD, John L
Weiss, MD, Mark
Flomenberg, MD, Neal
Grosso, DNP, Dolores

April 2014

Introduction: HSCT is a curative option for many patients (pts) with hematological malignancies. Si...

Analysis of Clinical Efficacy and Prognosis in 83 Cases Receiving Haploidentical Hematopoietic Stem Cell Transplantation for Hematological Malignancies

王萌
董玉君
邱志祥
刘微
任汉云

January 2016

目的:进一步总结单倍体相合造血干细胞移植的临床经验,并探讨其疗效.方法:比较83例单倍体移植和本移植中心同期73例同胞全相合移植的疗效,并分析影响移植后生存的相关危险因素.结果:单倍体移植组与全相合移...

Long-Term Survival and Late Effects among One-Year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Syndromes

January 2015

AbstractWe analyzed the outcomes of patients who survived disease-free for 1 year or more after a se...

Long term outcomes of 176 patients with X-linked hyper IgM syndrome treated with or without hematopoietic cell transplantation

January 2016

BACKGROUND: X-linked hyper IgM syndrome (XHIGM) is a primary immunodeficiency with high morbidity an...

Long-term prognosis for 1-year relapse-free survivors of CD34 cell-selected allogeneic hematopoietic stem cell transplantation : a landmark analysis

Cho, Christina
Hsu, Meier
Barba, Pere
Maloy, Molly A.
Avecilla, Scott T.
Barker, Juliet N.
Castro-Malaspina, Hugo
Giralt, Sergio A.
Jakubowski, Ann A.
Koehne, Guenther
Meagher, Richard C.
O'Reilly, Richard J.
Papadopoulos, Esperanza B.
Ponce, Doris M.
Tamari, Roni
van den Brink, Marcel R. M.
Young, James W.
Devlin, Sean M.
Perales, Miguel-Angel
Universitat Autònoma de Barcelona

January 2017

Altres ajuts: This research was supported in part by National Institutes of Health award number P01 ...

Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT

van Gorkom, Gwendolyn
van Gelder, Michel
Eikema, Dirk-Jan
Blok, Henric-Jan
van Lint, M. T.
Koc, Yener
Ciceri, Fabio
Beelen, Dietrich
Chevallier, Patrice
Selleslag, Dominik
Blaise, Didier
Foá, Roberto
Corradini, Paolo
Castagna, Luca
Moreno, Carol
Solano, Carlos
Müller, Lutz Peter
Tischer, Johanna
Hilgendorf, Inken
Hallek, Michael
Bittenbring, Jörg
Theobald, Matthias
Schetelig, Johannes
Kröger, Nicolaus

January 2018

Allogeneic hematopoietic stem cell transplantation (HCT) may result in long-term disease control in ...

Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.

Muraro, Paolo A
Pasquini, Marcelo
Atkins, Harold L
Bowen, James D
Farge, Dominique
Fassas, Athanasios
Freedman, Mark S
Georges, George E
Gualandi, Francesca
Hamerschlak, Nelson
Havrdova, Eva
Kimiskidis, Vassilios K
Kozak, Tomas
Mancardi, Giovanni L
Massacesi, Luca
Moraes, Daniela A
Nash, Richard A
Pavletic, Steven
Ouyang, Jian
Rovira, Montserrat
Saiz, Albert
Simoes, Belinda
Trnený, Marek
Zhu, Lin
Badoglio, Manuela
Zhong, Xiaobo
Sormani, Maria Pia
Saccardi, Riccardo

April 2017

Importance: Autologous hematopoietic stem cell transplantation (AHSCT) may be effective in aggressiv...

Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study

Greinix, Hildegard T
Eikema, Dirk-Jan
Koster, Linda
Penack, Olaf
Yakoub-Agha, Ibrahim
Montoto, Silvia
Chabannon, Christian
Styczynski, Jan
Nagler, Arnon
Robin, Marie
Robinson, Stephen
Chalandon, Yves
Mikulska, Malgorzata
Schönland, Stefan
Peric, Zinaida
Ruggeri, Annalisa
Lanza, Francesco
De Wreede, Liesbeth C
Mohty, Mohamad
Basak, Grzegorz W
Kröger, Nicolaus

January 2022

Acute graft-versus-host disease (aGvHD) remains a major threat to successful outcome after allogenei...

Long-Term Survival and Late Effects among One-Year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Syndromes

January 2015

We analyzed the outcomes of patients who survived disease-free for 1 year or more after a second all...

Long-Term Survival and Late Effects among One-Year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Syndromes

January 2015

We analyzed the outcomes of patients who survived disease-free for 1 year or more after a second all...

Treatment Pathways and Health Outcomes of German Patients with Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Health Claims Data Analysis

Scheid, Christof
Kudernatsch, Robert
Eckart, Marie
Feig, Chiara
Straub, Vincent
Libutzki, Berit
Mahlich, Jörg

December 2022

Background: Although chronic graft-versus-host-disease (cGvHD) is an important long-term complicatio...

Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study

Greinix, Hildegard T
Eikema, Dirk-Jan
Koster, Linda
Penack, Olaf
Yakoub-Agha, Ibrahim
Montoto, Silvia
Chabannon, Christian
Styczynski, Jan
Nagler, Arnon
Robin, Marie
Robinson, Stephen
Chalandon, Yves
Mikulska, Malgorzata
Schönland, Stefan
Peric, Zinaida
Ruggeri, Annalisa
Lanza, Francesco
De Wreede, Liesbeth C
Mohty, Mohamad
Basak, Grzegorz W
Kröger, Nicolaus

January 2022

Acute graft-versus-host disease (aGvHD) remains a major threat to successful outcome after allogenei...

Outcomes of Older Patients Undergoing 2-Step Approach to Haploidentical and Matched Related Peripheral Blood Hematopoietic Stem Cell Transplantation (HSCT): A Single Institutional Experience

Gaballa, MD, Sameh
Alpdogan, MD, Seyfettin Onder
Carabasi, MD, Matthew
Filicko-O\u27Hara, MD, Joanne
Kasner, MD, Margaret
Leiby, PhD, Benjamin E
Martinez-Outshoorn, MD, Ubaldo E.
Pequignot, MD, Edward C
Rosado, Sarah
Rudolph, MS, Shannon
Wagner, MD, John L
Weiss, MD, Mark
Flomenberg, MD, Neal
Grosso, DNP, Dolores

April 2014

Introduction: HSCT is a curative option for many patients (pts) with hematological malignancies. Si...

Analysis of Clinical Efficacy and Prognosis in 83 Cases Receiving Haploidentical Hematopoietic Stem Cell Transplantation for Hematological Malignancies

王萌
董玉君
邱志祥
刘微
任汉云

January 2016

目的:进一步总结单倍体相合造血干细胞移植的临床经验,并探讨其疗效.方法:比较83例单倍体移植和本移植中心同期73例同胞全相合移植的疗效,并分析影响移植后生存的相关危险因素.结果:单倍体移植组与全相合移...

Long-Term Survival and Late Effects among One-Year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Syndromes

January 2015

AbstractWe analyzed the outcomes of patients who survived disease-free for 1 year or more after a se...

Long term outcomes of 176 patients with X-linked hyper IgM syndrome treated with or without hematopoietic cell transplantation

January 2016

BACKGROUND: X-linked hyper IgM syndrome (XHIGM) is a primary immunodeficiency with high morbidity an...

Long-term prognosis for 1-year relapse-free survivors of CD34 cell-selected allogeneic hematopoietic stem cell transplantation : a landmark analysis

Cho, Christina
Hsu, Meier
Barba, Pere
Maloy, Molly A.
Avecilla, Scott T.
Barker, Juliet N.
Castro-Malaspina, Hugo
Giralt, Sergio A.
Jakubowski, Ann A.
Koehne, Guenther
Meagher, Richard C.
O'Reilly, Richard J.
Papadopoulos, Esperanza B.
Ponce, Doris M.
Tamari, Roni
van den Brink, Marcel R. M.
Young, James W.
Devlin, Sean M.
Perales, Miguel-Angel
Universitat Autònoma de Barcelona

January 2017

Altres ajuts: This research was supported in part by National Institutes of Health award number P01 ...

Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT

van Gorkom, Gwendolyn
van Gelder, Michel
Eikema, Dirk-Jan
Blok, Henric-Jan
van Lint, M. T.
Koc, Yener
Ciceri, Fabio
Beelen, Dietrich
Chevallier, Patrice
Selleslag, Dominik
Blaise, Didier
Foá, Roberto
Corradini, Paolo
Castagna, Luca
Moreno, Carol
Solano, Carlos
Müller, Lutz Peter
Tischer, Johanna
Hilgendorf, Inken
Hallek, Michael
Bittenbring, Jörg
Theobald, Matthias
Schetelig, Johannes
Kröger, Nicolaus

January 2018

Allogeneic hematopoietic stem cell transplantation (HCT) may result in long-term disease control in ...

Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.

Muraro, Paolo A
Pasquini, Marcelo
Atkins, Harold L
Bowen, James D
Farge, Dominique
Fassas, Athanasios
Freedman, Mark S
Georges, George E
Gualandi, Francesca
Hamerschlak, Nelson
Havrdova, Eva
Kimiskidis, Vassilios K
Kozak, Tomas
Mancardi, Giovanni L
Massacesi, Luca
Moraes, Daniela A
Nash, Richard A
Pavletic, Steven
Ouyang, Jian
Rovira, Montserrat
Saiz, Albert
Simoes, Belinda
Trnený, Marek
Zhu, Lin
Badoglio, Manuela
Zhong, Xiaobo
Sormani, Maria Pia
Saccardi, Riccardo

April 2017

Importance: Autologous hematopoietic stem cell transplantation (AHSCT) may be effective in aggressiv...

Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study

Greinix, Hildegard T
Eikema, Dirk-Jan
Koster, Linda
Penack, Olaf
Yakoub-Agha, Ibrahim
Montoto, Silvia
Chabannon, Christian
Styczynski, Jan
Nagler, Arnon
Robin, Marie
Robinson, Stephen
Chalandon, Yves
Mikulska, Malgorzata
Schönland, Stefan
Peric, Zinaida
Ruggeri, Annalisa
Lanza, Francesco
De Wreede, Liesbeth C
Mohty, Mohamad
Basak, Grzegorz W
Kröger, Nicolaus

January 2022

Acute graft-versus-host disease (aGvHD) remains a major threat to successful outcome after allogenei...

Long-Term Survival and Late Effects among One-Year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Syndromes

January 2015

We analyzed the outcomes of patients who survived disease-free for 1 year or more after a second all...

Long-Term Survival and Late Effects among One-Year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Syndromes

January 2015

We analyzed the outcomes of patients who survived disease-free for 1 year or more after a second all...

Treatment Pathways and Health Outcomes of German Patients with Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Health Claims Data Analysis

Scheid, Christof
Kudernatsch, Robert
Eckart, Marie
Feig, Chiara
Straub, Vincent
Libutzki, Berit
Mahlich, Jörg

December 2022

Background: Although chronic graft-versus-host-disease (cGvHD) is an important long-term complicatio...

Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study

Greinix, Hildegard T
Eikema, Dirk-Jan
Koster, Linda
Penack, Olaf
Yakoub-Agha, Ibrahim
Montoto, Silvia
Chabannon, Christian
Styczynski, Jan
Nagler, Arnon
Robin, Marie
Robinson, Stephen
Chalandon, Yves
Mikulska, Malgorzata
Schönland, Stefan
Peric, Zinaida
Ruggeri, Annalisa
Lanza, Francesco
De Wreede, Liesbeth C
Mohty, Mohamad
Basak, Grzegorz W
Kröger, Nicolaus

January 2022

Acute graft-versus-host disease (aGvHD) remains a major threat to successful outcome after allogenei...